ArticleCureus2026
Study of Cardiovascular Dysfunction in Cirrhosis and Its Correlation With Severity at a Tertiary Care Hospital.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCirrhosis of the liver is accompanied by systemic circulatory changes that can give rise to cardiovascular changes collectively termed cirrhotic cardiomyopathy. While these changes can be clinically silent, they can aggravate conditions, especially in the later stages of liver disease. The current study aims to examine cardiovascular dysfunction in patients with cirrhosis and its relationship with disease severity.
methodsBetween April 2023 and June 2024, a study was carried out at Srirama Chandra Bhanja Medical College and Hospital in Cuttack, involving 103 participants. Each patient underwent a series of evaluations, including echocardiography, laboratory tests, electrocardiography (ECG), and clinical examinations. Additionally, the Child-Turcotte-Pugh (CTP) classification was utilized to assess the severity of cirrhosis. To evaluate cardiac dysfunction, cardiology blood tests, ECG, and echocardiography were performed to measure the left ventricular ejection fraction.
resultsThe mean age of the study population was 44.22 ± 10.97 years (n = 103), with 66 male (64%) and 37 female (36%) participants. Alcohol-related liver disease was the most common etiology (72 patients, 69.9%). Diastolic dysfunction was the most frequent cardiac abnormality and increased significantly with worsening CTP class (p < 0.05). Systolic dysfunction was less common, with most patients demonstrating preserved ejection fraction. ECG abnormalities, including QT interval prolongation, were observed in a subset of patients. Given the predominance of alcohol-related cirrhosis, the potential independent contribution of alcohol to cardiac abnormalities should also be considered.
conclusionCardiovascular dysfunction, particularly diastolic dysfunction, is common in cirrhotic patients and correlates with the severity of liver disease. However, the high proportion of alcohol-related cirrhosis in the study population may have influenced the observed cardiac findings. Routine cardiovascular assessment may facilitate early detection and improved clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.